PMIHealthcare · Medical Devices

PMI Stock Forecast: Picard Medical, Inc. Price Predictions for 2026-2027

Last close, 20 Nov 2026
$6.79
+7.78% on the day

Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 18 of 100 as at 21 Nov 2026 — in the weakest quartile.

Market cap
$18.1M
Ticker Nerd rank
18/ 100
Median analyst target
—
Analysts covering
1
Revenue$3.0M+38.6% y/y
Operating income−$4.6M
Net income−$5.7M
Free cash flow−$1.4M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−6.1%
1M
−35.2%
YTD
−92.2%
1Y
−93.8%
From 52W high
−96.3%
From 52W low
+124.1%
$3
$185
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

One number for the whole business

Consensus tells you what everyone already believes. The model scores Picard Medical, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 21 Nov 2026
18/ 100

Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Accruals
94
Growth
56
Volatility
23
Revisions
20
Quality
19
Momentum
15
Value
13
Issuance
6

Accruals (94): Reported profit is backed by cash, and the company is not expanding recklessly.

Issuance (6): The company has been issuing shares or taking on financing, diluting existing holders.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

PMI stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on PMI, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$0$50$100$150Jan 26Apr 26Jul 26Oct 26PMI

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says1 analysts
0
Buy
1
Hold
0
Sell
Recent analyst actionsNewest first
DateFirmActionRatingTarget
3 June 2026HC Wainwright & Co.ReiteratesNeutral—
18 May 2026HC Wainwright & Co.InitiatesNeutral—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Wall Street targets run 12 to 18 months out. No analyst publishes a 2030 price target for PMI.

Market Radar

This page is one stock. Monday covers all of them.

PMI appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.

Free. Unsubscribe any time. Privacy

The AI build-out map
PDF
  • AI cloud capacity

    MSFTAMZNGOOGLORCL

  • AI chips

    NVDAAVGOAMDMU

  • AI networking and servers

    ANETDELLLITECRDO

  • Data centre power

    VRTCEGGEVVST

Performance

PMI vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 20 Nov 2026, Picard Medical, Inc. returned −93.8% against +6.9% for the S&P 500, dividends included.

PMI vs S&P 500, last 12 monthsTotal return, rebased to 100
050100150Jan 26Apr 26Jul 26Oct 26PMIS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

PMI analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingThis fiscal year
Analysts raising
0
Analysts cutting
0
Fundamentals

Financials

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
3.0×

Cheaper than 89% of US stocks

Price / sales
3.4×

Cheaper than 32% of US stocks

Price / book
12.6×

Cheaper than 6% of US stocks

EV / EBITDA
—
Growth & margins
Revenue growth (YoY)
—
Earnings growth (YoY)
—
Gross margin
20.9%

Higher than 22% of US stocks

Operating margin
—
Net margin
—
Returns & dividend
Return on equity
−425.6%

Higher than 3% of US stocks

Return on assets
−78.8%

Higher than 4% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.

Statistics

Key statistics

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Picard Medical, Inc. has a market value of $18.1M and an enterprise value of $20.6M.

  • Revenue in the twelve months to 30 June 2026: $6.3M. The latest quarter grew 38.6% year on year.

  • Net income over the same four quarters: −$28.0M, a −444.3% net margin.

  • Free cash flow in the twelve months to 30 June 2026: −$16.1M.

  • Shares outstanding: 2.1M.

  • Trailing P/E: 3.0×.

  • Picard Medical, Inc. employs 75 people — $84K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 21 Nov 2026

Data provided by Twelve Data

Peers

PMI and its peers

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Devices
CompanyMarket capTKN rank
PMIPicard Medical, Inc.$18.1M18
NNOXNano-X Imaging Ltd.$17.7M17
MODDModular Medical, Inc.$16.0M12
CVRXCVRx, Inc.$14.3M20
CTSOCytoSorbents Corp.$13.1M70
SNWVSANUWAVE Health, Inc.$12.9M53
ITOCiTonic Holdings Ltd.$11.6M15

Take a look at PMI’s peer groups, ranked by the model: healthcare stocks.

Look up any of the roughly 4,300 stocks we score.

The rank is the raw material. Whether the rules would actually own Picard Medical, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

FAQ

Questions about PMI

Is PMI stock a buy right now?

Of the 1 analyst covering Picard Medical, Inc., 0 rate it a Buy, 1 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Picard Medical, Inc. 18 out of 100 across roughly 4,300 US stocks as at 21 Nov 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank PMI?

As at 21 Nov 2026, Picard Medical, Inc. ranks 18 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Accruals (94 of 100).

What is the PMI stock forecast for 2030?

No analyst covering Picard Medical, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for PMI are extrapolating price history, which says nothing about the business.

How has PMI stock performed over the past year?

Picard Medical, Inc. returned -93.8% over the 12 months to 20 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Picard Medical, Inc. do?

Picard Medical Inc. is a medical technology company focused on designing, manufacturing, and commercializing the SynCardia Total Artificial Heart, an implantable device used for patients with advanced heart failure. Through its subsidiary SynCardia Systems, the company develops and supplies total artificial heart therapy products that support patients who need temporary or bridge-to-transplant cardiac replacement options.

Company

About Picard Medical, Inc.

Picard Medical Inc. is a medical technology company focused on designing, manufacturing, and commercializing the SynCardia Total Artificial Heart, an implantable device used for patients with advanced heart failure. Through its subsidiary SynCardia Systems, the company develops and supplies total artificial heart therapy products that support patients who need temporary or bridge-to-transplant cardiac replacement options. Its business is centered on medical device production, marketing, and distribution across the United States, Europe, and other international markets. Based in Tucson, Arizona, Picard Medical Inc. plays a specialized role in the healthcare equipment sector by addressing a highly critical segment of cardiac support and artificial organ technology.

CEO Dr. Yuncai Fang Ph.D. · 75 employees · United States · https://www.picardmedical.com